This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakai, H.
Right arrow Articles by Kay, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakai, H.
Right arrow Articles by Kay, M. A.

 Previous Article  |  Next Article 

Journal of Virology, January 2005, p. 214-224, Vol. 79, No. 1
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.1.214-224.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Unrestricted Hepatocyte Transduction with Adeno-Associated Virus Serotype 8 Vectors in Mice

Hiroyuki Nakai,1* Sally Fuess,1 Theresa A. Storm,1 Shin-ichi Muramatsu,2 Yuko Nara,2 and Mark A. Kay1,3

Departments of Pediatrics,1 Genetics, Stanford University School of Medicine, Stanford, California,3 Neurology, Department of Medicine, Jichi Medical School, Minamikawachi, Tochigi, Japan2

Received 18 May 2004/ Accepted 20 August 2004

Recombinant adeno-associated virus (rAAV) vectors can mediate long-term stable transduction in various target tissues. However, with rAAV serotype 2 (rAAV2) vectors, liver transduction is confined to only a small portion of hepatocytes even after administration of extremely high vector doses. In order to investigate whether rAAV vectors of other serotypes exhibit similar restricted liver transduction, we performed a dose-response study by injecting mice with ß-galactosidase-expressing rAAV1 and rAAV8 vectors via the portal vein. The rAAV1 vector showed a blunted dose-response similar to that of rAAV2 at high doses, while the rAAV8 vector dose-response remained unchanged at any dose and ultimately could transduce all the hepatocytes at a dose of 7.2 x 1012 vector genomes/mouse without toxicity. This indicates that all hepatocytes have the ability to process incoming single-stranded vector genomes into duplex DNA. A single tail vein injection of the rAAV8 vector was as efficient as portal vein injection at any dose. In addition, intravascular administration of the rAAV8 vector at a high dose transduced all the skeletal muscles throughout the body, including the diaphragm, the entire cardiac muscle, and substantial numbers of cells in the pancreas, smooth muscles, and brain. Thus, rAAV8 is a robust vector for gene transfer to the liver and provides a promising research tool for delivering genes to various target organs. In addition, the rAAV8 vector may offer a potential therapeutic agent for various diseases affecting nonhepatic tissues, but great caution is required for vector spillover and tight control of tissue-specific gene expression.

* Corresponding author. Mailing address: Department of Pediatrics, Stanford University School of Medicine, 300 Pasteur Dr., Grant Bldg., Rm. S374, Stanford, CA 94305. Phone: (650) 498-2753. (650) 725-7487. Fax: (650) 736-2068. E-mail: nakaih{at}stanford.edu.

Journal of Virology, January 2005, p. 214-224, Vol. 79, No. 1
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.1.214-224.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Goehringer, C., Rutschow, D., Bauer, R., Schinkel, S., Weichenhan, D., Bekeredjian, R., Straub, V., Kleinschmidt, J. A., Katus, H. A., Muller, O. J. (2009). Prevention of cardiomyopathy in {delta}-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors. Cardiovasc Res 82: 404-410 [Abstract] [Full Text]  
  • Davis, J., Westfall, M. V., Townsend, D., Blankinship, M., Herron, T. J., Guerrero-Serna, G., Wang, W., Devaney, E., Metzger, J. M. (2008). Designing Heart Performance by Gene Transfer. Physiol. Rev. 88: 1567-1651 [Abstract] [Full Text]  
  • Inagaki, K., Piao, C., Kotchey, N. M., Wu, X., Nakai, H. (2008). Frequency and Spectrum of Genomic Integration of Recombinant Adeno-Associated Virus Serotype 8 Vector in Neonatal Mouse Liver. J. Virol. 82: 9513-9524 [Abstract] [Full Text]  
  • Doege, H., Grimm, D., Falcon, A., Tsang, B., Storm, T. A., Xu, H., Ortegon, A. M., Kazantzis, M., Kay, M. A., Stahl, A. (2008). Silencing of Hepatic Fatty Acid Transporter Protein 5 in Vivo Reverses Diet-induced Non-alcoholic Fatty Liver Disease and Improves Hyperglycemia. J. Biol. Chem. 283: 22186-22192 [Abstract] [Full Text]  
  • Ho, K. J., Bass, C. E., Kroemer, A. H. K., Ma, C., Terwilliger, E., Karp, S. J. (2008). Optimized adeno-associated virus 8 produces hepatocyte-specific Cre-mediated recombination without toxicity or affecting liver regeneration. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G412-G419 [Abstract] [Full Text]  
  • Grimm, D., Lee, J. S., Wang, L., Desai, T., Akache, B., Storm, T. A., Kay, M. A. (2008). In Vitro and In Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated Viruses. J. Virol. 82: 5887-5911 [Abstract] [Full Text]  
  • Inagaki, K., Ma, C., Storm, T. A., Kay, M. A., Nakai, H. (2007). The Role of DNA-PKcs and Artemis in Opening Viral DNA Hairpin Termini in Various Tissues in Mice. J. Virol. 81: 11304-11321 [Abstract] [Full Text]  
  • Inagaki, K., Lewis, S. M., Wu, X., Ma, C., Munroe, D. J., Fuess, S., Storm, T. A., Kay, M. A., Nakai, H. (2007). DNA Palindromes with a Modest Arm Length of {gtrsim}20 Base Pairs Are a Significant Target for Recombinant Adeno-Associated Virus Vector Integration in the Liver, Muscles, and Heart in Mice. J. Virol. 81: 11290-11303 [Abstract] [Full Text]  
  • Wang, J., Xie, J., Lu, H., Chen, L., Hauck, B., Samulski, R. J., Xiao, W. (2007). Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction. Proc. Natl. Acad. Sci. USA 104: 13104-13109 [Abstract] [Full Text]  
  • Nathwani, A. C., Gray, J. T., McIntosh, J., Ng, C. Y. C., Zhou, J., Spence, Y., Cochrane, M., Gray, E., Tuddenham, E. G. D., Davidoff, A. M. (2007). Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates. Blood 109: 1414-1421 [Abstract] [Full Text]  
  • Muller, O. J., Katus, H. A., Bekeredjian, R. (2007). Targeting the heart with gene therapy-optimized gene delivery methods. Cardiovasc Res 73: 453-462 [Abstract] [Full Text]  
  • Akache, B., Grimm, D., Pandey, K., Yant, S. R., Xu, H., Kay, M. A. (2006). The 37/67-Kilodalton Laminin Receptor Is a Receptor for Adeno-Associated Virus Serotypes 8, 2, 3, and 9. J. Virol. 80: 9831-9836 [Abstract] [Full Text]  
  • Wu, Z., Miller, E., Agbandje-McKenna, M., Samulski, R. J. (2006). {alpha}2,3 and {alpha}2,6 N-Linked Sialic Acids Facilitate Efficient Binding and Transduction by Adeno-Associated Virus Types 1 and 6.. J. Virol. 80: 9093-9103 [Abstract] [Full Text]  
  • Kitajima, K., Marchadier, D. H.L., Miller, G. C., Gao, G.-p., Wilson, J. M., Rader, D. J. (2006). Complete Prevention of Atherosclerosis in ApoE-Deficient Mice by Hepatic Human ApoE Gene Transfer With Adeno-Associated Virus Serotypes 7 and 8. Arterioscler. Thromb. Vasc. Bio. 26: 1852-1857 [Abstract] [Full Text]  
  • Wang, Z., Zhu, T., Rehman, K. K., Bertera, S., Zhang, J., Chen, C., Papworth, G., Watkins, S., Trucco, M., Robbins, P. D., Li, J., Xiao, X. (2006). Widespread and Stable Pancreatic Gene Transfer by Adeno-Associated Virus Vectors via Different Routes.. Diabetes 55: 875-884 [Abstract] [Full Text]  
  • Nathwani, A. C., Gray, J. T., Ng, C. Y. C., Zhou, J., Spence, Y., Waddington, S. N., Tuddenham, E. G. D., Kemball-Cook, G., McIntosh, J., Boon-Spijker, M., Mertens, K., Davidoff, A. M. (2006). Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. Blood 107: 2653-2661 [Abstract] [Full Text]  
  • Grimm, D., Pandey, K., Nakai, H., Storm, T. A., Kay, M. A. (2006). Liver Transduction with Recombinant Adeno-Associated Virus Is Primarily Restricted by Capsid Serotype Not Vector Genotype. J. Virol. 80: 426-439 [Abstract] [Full Text]  
  • Dodge, J. C., Clarke, J., Song, A., Bu, J., Yang, W., Taksir, T. V., Griffiths, D., Zhao, M. A., Schuchman, E. H., Cheng, S. H., O'Riordan, C. R., Shihabuddin, L. S., Passini, M. A., Stewart, G. R. (2005). Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease. Proc. Natl. Acad. Sci. USA 102: 17822-17827 [Abstract] [Full Text]  
  • Zhu, T., Zhou, L., Mori, S., Wang, Z., McTiernan, C. F., Qiao, C., Chen, C., Wang, D. W., Li, J., Xiao, X. (2005). Sustained Whole-Body Functional Rescue in Congestive Heart Failure and Muscular Dystrophy Hamsters by Systemic Gene Transfer. Circulation 112: 2650-2659 [Abstract] [Full Text]  
  • Qiao, C., Li, J., Zhu, T., Draviam, R., Watkins, S., Ye, X., Chen, C., Li, J., Xiao, X. (2005). Amelioration of laminin-{alpha}2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin. Proc. Natl. Acad. Sci. USA 102: 11999-12004 [Abstract] [Full Text]  
  • Bernardi, F. (2005). Gain-of-function proteins for gene transfer in hemophilia. Blood 105: 2243-2243 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»